Thor Medical A Stock

Thor Medical A EBIT

The EBIT of Thor Medical A (TRMED.OL) as of Aug 13, 2026 is -7.20 M NOK. In the previous year, EBIT was -317.36 M NOK — a change of -97.73% (higher).

EBIT

-7.20 MNOK

YoY

-97.73%

Last updated:

In 2026, Thor Medical A's EBIT was -7.20 M NOK, a -97.73% increase from the -317.36 M NOK EBIT recorded in the previous year.

The Thor Medical A EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M NOK)
Date
EBIT (M NOK)
Jan 1, 2021
-442.43 base
Jan 1, 2022
-317.36 base
Jan 1, 2023
-7.20 base
Jan 1, 2025 (e)
1.80 base
Jan 1, 2026 (e)
29.40 base
Jan 1, 2027 (e)
100.80 base
Jan 1, 2028 (e)
110.40 base
Jan 1, 2029 (e)
362.40 base
YEAREBIT (M NOK)
2029 est 362.40
2028 est 110.40
2027 est 100.80
2026 est 29.40
2025 est 1.80
2023 -7.20
2022 -317.36
2021 -442.43
2020 -434.16
2019 -440.35
2018 -340.01
2017 -316.52
2016 -216.36
2015 -183.10
2014 -68.67
2013 -18.11
2012 -13.75
Access this data via the Eulerpool API

Thor Medical A Revenue

Thor Medical A Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
0.00 NOK
-442.43 M NOK
-441.30 M NOK
Jan 1, 2022
0.00 NOK
-317.36 M NOK
-311.24 M NOK
Jan 1, 2023
0.00 NOK
-7.20 M NOK
-26.56 M NOK
Jan 1, 2025 (e)
3.00 M NOK
1.80 M NOK
-88.52 M NOK
Jan 1, 2026 (e)
49.00 M NOK
29.40 M NOK
-49.57 M NOK
Jan 1, 2027 (e)
168.00 M NOK
100.80 M NOK
-38.95 M NOK
Jan 1, 2028 (e)
184.00 M NOK
110.40 M NOK
-24.79 M NOK
Jan 1, 2029 (e)
604.00 M NOK
362.40 M NOK
70.82 M NOK

Thor Medical A Margins

Thor Medical A stock margins

The Thor Medical A margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Thor Medical A. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Thor Medical A.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
0.00 %
- %
- %
Jan 1, 2022
0.00 %
- %
- %
Jan 1, 2023
0.00 %
- %
- %
Jan 1, 2025 (e)
0.00 %
60.00 %
-2,950.67 %
Jan 1, 2026 (e)
0.00 %
60.00 %
-101.17 %
Jan 1, 2027 (e)
0.00 %
60.00 %
-23.18 %
Jan 1, 2028 (e)
0.00 %
60.00 %
-13.47 %
Jan 1, 2029 (e)
0.00 %
60.00 %
11.72 %

Thor Medical A Stock analysis

What does Thor Medical A do? Nordic Nanovector ASA is a Norwegian biopharmaceutical company specializing in the development and commercialization of therapies for the treatment of lymphoma and other cancers. The company was founded in 2009 by a group of leading scientists in the field of cancer research, focused on developing new and innovative treatment options for cancer. Nordic Nanovector's business model is based on the use of antibodies specifically targeted to cancer cells. An example of this is the drug Betalutin, which contains a radioactive substance that selectively destroys cancer cells. Betalutin has been tested in multiple clinical trials and has shown promising results in the treatment of non-Hodgkin lymphoma. In addition to Betalutin, the company also has another technology platform based on the use of antibodies with high affinity to specific types of cancer. Nordic Nanovector also manufactures a wide range of diagnostic tools that can be used in cancer research. Since its inception, Nordic Nanovector has received numerous national and international awards and prizes for its innovative products and technologies. The company has established relationships with various academic institutions and organizations to advance research and development. In addition to product development, the company has undergone an impressive capital raise to advance the development of these therapies. Nordic Nanovector has received several public and private financings in recent years to support and expand its research activities. In 2015, the company went public on the Oslo Stock Exchange, foregoing the conquest of the US market. The foundation of the company's portfolio is protected by technology patents and product patents. The company has undergone several challenging development and approval steps to gain a competitive advantage over competitors. The goal is to promote long-term growth and availability of the products worldwide. Nordic Nanovector believes that its business model is realized based on innovative technologies in cancer research. With a focus on the development of therapies and diagnostic tools, the company has built significant potential in the industry. The future prospects and growth outlook are positive and are expected to contribute to even greater success for Nordic Nanovector in the future. Thor Medical A is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Thor Medical A's EBIT

Thor Medical A's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Thor Medical A's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Thor Medical A's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Thor Medical A’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Thor Medical A stock

EBIT of Thor Medical A is -7.20 M NOK in 2026.

EBIT of Thor Medical A changed from -317.36 M NOK to -7.20 M NOK, representing a -97.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Thor Medical A since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's NOK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Thor Medical A historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Thor Medical A

All Key Metrics — Thor Medical A